Key Takeaways

• Autoimmune diseases occur when the immune system attacks the body’s own tissues.
• Many autoimmune conditions are associated with increased inflammation and insulin resistance.
• Conventional treatments rely on anti-inflammatory and immunosuppressive drugs.
• AMPK activation plays a central role in reducing cellular inflammation.
• Metabolic Engineering® combines the Zone diet, omega-3 fatty acids, and polyphenols to reduce inflammation and improve metabolic health.

Autoimmune diseases occur when the immune system mistakenly attacks healthy tissues. While the exact cause is still being studied, growing evidence suggests that chronic inflammation and metabolic dysfunction—especially insulin resistance—may play an important role.

Metabolic Engineering®, developed by Dr. Barry Sears, focuses on restoring metabolic balance to reduce inflammation and support immune regulation.

What Are Autoimmune Diseases?

Autoimmune conditions develop when the immune system begins to attack normal tissues instead of protecting them.

Examples include:

• Rheumatoid arthritis
• Lupus
• Psoriasis
• Multiple sclerosis
• Irritable bowel syndrome

In these conditions, the immune system loses the ability to properly distinguish between “self” and “foreign” cells, triggering chronic inflammatory attacks against healthy tissue.

Although the exact cause of autoimmune disease remains unclear, research suggests that metabolic dysfunction and insulin resistance may contribute to immune system dysregulation (1).

The Traditional Medical Approach to Autoimmune Disease

Standard treatment strategies focus on reducing inflammation and suppressing immune activity.

Common medications include:

• Non-steroidal anti-inflammatory drugs (NSAIDs)
• Corticosteroids
• Monoclonal antibody therapies

While these drugs can reduce symptoms, they may also weaken the immune system’s ability to:

• fight infections
• repair tissue
• recover from physical injuries

Because autoimmune disease is strongly associated with increased insulin resistance, managing underlying metabolic dysfunction may provide an additional strategy for improving outcomes.

The Metabolic Engineering® Approach

Metabolic Engineering® provides a dietary strategy designed to reduce cellular inflammation by activating AMPK (AMP-activated protein kinase).

AMPK acts as a master regulator of metabolism and plays an important role in controlling inflammatory pathways (2, 3).

1. The Zone Diet Component

The Zone diet promotes calorie restriction without hunger or fatigue, which increases AMPK activity.

Higher AMPK activity helps reduce the activation of the inflammatory gene transcription factor NF-κB.

Lower NF-κB activity decreases production of several inflammatory mediators, including:

• Pro-inflammatory eicosanoids
• Prostaglandins
• Leukotrienes
• Cytokines such as TNF-α

2. Omega-3 Fatty Acids

Omega-3 fatty acids provide a more targeted way to reduce inflammation.

They work by:

• inhibiting eicosanoid and leukotriene production
• supporting anti-inflammatory signaling pathways

Omega-3 fatty acids are also the building blocks for resolvins, specialized hormones that help repair damaged tissues and actively resolve inflammation.

3. Polyphenols

The polyphenol component of Metabolic Engineering® indirectly activates AMPK and increases the activity of Nrf2, a gene transcription factor that reduces oxidative stress.

Lower oxidative stress further decreases inflammatory signaling and supports healthier immune function.

How Metabolic Engineering® May Support Autoimmune Health

The consistent use of Metabolic Engineering® reduces chronic inflammation throughout the body.

Lower inflammation may help the immune system better recognize healthy cells as “self” instead of “foreign.”

By improving metabolic function, this approach may also allow:

• anti-inflammatory drugs to work more effectively
• physicians to reduce medication dosage
• fewer side effects from long-term treatment

Metabolic Engineering® therefore aims to reprogram metabolism to control inflammation, which may help support better management of autoimmune diseases.

References
1. Uddin J, Tran K, Hannan A, Rahman A, Lam A, Ngoc TN, Chu D. Autoimmune diseases and metabolic disorders: Molecular connections and potential therapeutic targets. Translational Autoimmunity. Elsevier (2002)

2. Noor HB, Mou NA, Salem L, Shimul MFA, Biswas S, Akther R, Khan S, Raihan S, Mohib MM, Sagor MAT. Anti-inflammatory property of AMP-activated protein kinase.  Antiinflamm Antiallergy Agents Med Chem. 2020; 19: 2-41. doi: 10.2174/1871523018666190830100022.

3. Sears B and Saha AK. Dietary control of inflammation and resolution. Front Nutr. 2021; 8:709435. doi: 10.3389/fnut.2021.709435.